Literature DB >> 6682634

Pertussis toxin uncouples dopamine agonist inhibition of prolactin release.

M J Cronin, G A Myers, R M MacLeod, E L Hewlett.   

Abstract

Pertussis toxin, a protein exotoxin produced by Bordetella pertussis, markedly reduced or eliminated the ability of dopamine or the dopamine agonist bromocriptine to inhibit prolactin release from anterior pituitary cells in vitro. Toxin-mediated reversal of the effect on dopamine agonist inhibition of prolactin release occurred with a lag of greater than 6 h, was maximal by 24 h, and persisted for at least 6 days after removal of the toxin from the medium. The toxin reduced dopamine agonist efficacy without altering potency or directly modifying the dopamine receptor (as measured by [3H]spiperone binding). The ability of dopamine to reduce cellular cyclic AMP content was also antagonized by pertussis toxin, supporting the hypothesis that reduction of cellular cyclic AMP content and inhibition of prolactin secretion may be causally related. These data demonstrated that pertussis toxin can prevent the typical inhibitory action of dopamine agonists on anterior pituitary prolactin release and suggest that this receptor-mediated inhibitory hormone system is analogous to other inhibitory receptors coupled to adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6682634     DOI: 10.1152/ajpendo.1983.244.5.E499

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  10 in total

Review 1.  Receptors and transduction mechanisms in anterior pituitary: primary cultures, transfected clonal cells and human tumor derived cells.

Authors:  A Enjalbert
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

Review 2.  Ion channels and signaling in the pituitary gland.

Authors:  Stanko S Stojilkovic; Joël Tabak; Richard Bertram
Journal:  Endocr Rev       Date:  2010-07-21       Impact factor: 19.871

3.  Pertussis toxin blocks the inhibitory effect of muscarinic cholinergic agonists on cyclic AMP accumulation and prolactin secretion in GH3 anterior-pituitary tumour cells.

Authors:  B L Brown; R J Wojcikiewicz; P R Dobson; A Robinson; L I Irons
Journal:  Biochem J       Date:  1984-10-01       Impact factor: 3.857

4.  Promotion of lipolysis in rat adipocytes by pertussis toxin: reversal of endogenous inhibition.

Authors:  L Olansky; G A Myers; S L Pohl; E L Hewlett
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

5.  The relationship between pertussis-toxin-induced ADP-ribosylation of a plasma-membrane protein and reversal of muscarinic inhibition of prolactin secretion in GH3 cells.

Authors:  R J Wojcikiewicz; P R Dobson; L I Irons; A Robinson; B L Brown
Journal:  Biochem J       Date:  1984-11-15       Impact factor: 3.857

6.  Estrogen regulation of the dopamine-activated GIRK channel in pituitary lactotrophs: implications for regulation of prolactin release during the estrous cycle.

Authors:  Heather R Christensen; Qinghua Zeng; Michael K Murawsky; Karen A Gregerson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-08       Impact factor: 3.619

7.  Functional expression of the dopamine-activated K(+) current in lactotrophs during the estrous cycle in female rats: correlation with prolactin secretory responses.

Authors:  Karen A Gregerson
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

8.  Guanine nucleotide binding proteins mediate D2 dopamine receptor activation of a potassium channel in rat lactotrophs.

Authors:  L C Einhorn; G S Oxford
Journal:  J Physiol       Date:  1993-03       Impact factor: 5.182

9.  In vivo effects of estrogen and 2-hydroxyestradiol on D-2 dopamine receptor agonist affinity states in rat striatum.

Authors:  J Clopton; J H Gordon
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

10.  Dopamine inhibits basal prolactin release in pituitary lactotrophs through pertussis toxin-sensitive and -insensitive signaling pathways.

Authors:  Arturo E Gonzalez-Iglesias; Takayo Murano; Shuo Li; Melanija Tomić; Stanko S Stojilkovic
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.